Literatura académica sobre el tema "Rv0158"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Índice
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Rv0158".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "Rv0158"
Casali, Nicola, Amy M. White y Lee W. Riley. "Regulation of the Mycobacterium tuberculosis mce1 Operon". Journal of Bacteriology 188, n.º 2 (15 de enero de 2006): 441–49. http://dx.doi.org/10.1128/jb.188.2.441-449.2006.
Texto completoSun, Y., Y. Wang, H. Wang, S. Wang, G. Ping y L. Zhang. "HLA-A*0201-restricted CTL epitopes in Rv0350 and Rv0351 of latent Mycobacterium tuberculosis". International Journal of Infectious Diseases 21 (abril de 2014): 306. http://dx.doi.org/10.1016/j.ijid.2014.03.1054.
Texto completoXu, Guangxian, Hao Jia, Yong Li, Xiaoming Liu, Min Li y Yujiong Wang. "Hemolytic phospholipaseRv0183of Mycobacterium tuberculosis induces inflammatory response and apoptosis in alveolar macrophage RAW264.7 cells". Canadian Journal of Microbiology 56, n.º 11 (noviembre de 2010): 916–24. http://dx.doi.org/10.1139/w10-079.
Texto completoGoldstone, Rachael M., Sunali D. Goonesekera, Barry R. Bloom y Samantha L. Sampson. "The Transcriptional Regulator Rv0485 Modulates the Expression of a pe and ppe Gene Pair and Is Required for Mycobacterium tuberculosis Virulence". Infection and Immunity 77, n.º 10 (3 de agosto de 2009): 4654–67. http://dx.doi.org/10.1128/iai.01495-08.
Texto completoCôtes, Karen, Rabeb Dhouib, Isabelle Douchet, Henri Chahinian, Alain de Caro, Frédéric Carrière y Stéphane Canaan. "Characterization of an exported monoglyceride lipase from Mycobacterium tuberculosis possibly involved in the metabolism of host cell membrane lipids". Biochemical Journal 408, n.º 3 (28 de noviembre de 2007): 417–27. http://dx.doi.org/10.1042/bj20070745.
Texto completoAbomoelak, Bassam, Elizabeth A. Hoye, Jing Chi, Sarah A. Marcus, Francoise Laval, John P. Bannantine, Sarah K. Ward, Mamadou Daffé, Hong Di Liu y Adel M. Talaat. "mosR, a Novel Transcriptional Regulator of Hypoxia and Virulence in Mycobacterium tuberculosis". Journal of Bacteriology 191, n.º 19 (31 de julio de 2009): 5941–52. http://dx.doi.org/10.1128/jb.00778-09.
Texto completoSharma, Divakar, Manju Lata, Mohammad Faheem, Asad Khan, Beenu Joshi, Krishnamurthy Venkatesan, Sangeeta Shukla y Deepa Bisht. "Cloning, Expression and Correlation of Rv0148 to Amikacin & Kanamycin Resistance". Current Proteomics 12, n.º 2 (3 de septiembre de 2015): 96–100. http://dx.doi.org/10.2174/157016461202150903113053.
Texto completoGurvitz, Aner, J. Kalervo Hiltunen y Alexander J. Kastaniotis. "Heterologous Expression of Mycobacterial Proteins in Saccharomyces cerevisiae Reveals Two Physiologically Functional 3-Hydroxyacyl-Thioester Dehydratases, HtdX and HtdY, in Addition to HadABC and HtdZ". Journal of Bacteriology 191, n.º 8 (9 de enero de 2009): 2683–90. http://dx.doi.org/10.1128/jb.01046-08.
Texto completoAnlay, Degefaye Zelalem, Emmanuel Rivière, Pham Hien Trang Tu, Steven Abrams y Annelies Van Rie. "A Bayesian approach to estimate the probability of resistance to bedaquiline in the presence of a genomic variant". PLOS ONE 18, n.º 6 (14 de junio de 2023): e0287019. http://dx.doi.org/10.1371/journal.pone.0287019.
Texto completoGrininger, Christoph, Mario Leypold, Philipp Aschauer, Tea Pavkov-Keller, Lina Riegler-Berket, Rolf Breinbauer y Monika Oberer. "Structural Changes in the Cap of Rv0183/mtbMGL Modulate the Shape of the Binding Pocket". Biomolecules 11, n.º 9 (1 de septiembre de 2021): 1299. http://dx.doi.org/10.3390/biom11091299.
Texto completoTesis sobre el tema "Rv0158"
Castell, Alina. "Fighting Tuberculosis – : Structural Studies of Three Mycobacterial Proteins". Doctoral thesis, Uppsala universitet, Strukturell molekylärbiologi, 2008. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-9348.
Texto completoShee, Somnath. "Manipulating Bacterial and Host Reactive Oxygen Species (ROS)- based mechanisms to potentiate killing of Mycobacterium tuberculosis (Mtb)". Thesis, 2021. https://etd.iisc.ac.in/handle/2005/5680.
Texto completoWelcome-DBT
Chaturvedi, Rashmi. "Functional Characterization Of Rv0754(PE_PGRS11) : A Multifunctional PE_PGRS Protein From Mycobacterium Tuberculosis". Thesis, 2009. https://etd.iisc.ac.in/handle/2005/991.
Texto completoChaturvedi, Rashmi. "Functional Characterization Of Rv0754(PE_PGRS11) : A Multifunctional PE_PGRS Protein From Mycobacterium Tuberculosis". Thesis, 2009. http://hdl.handle.net/2005/991.
Texto completoVillellas, C., N. Coeck, Conor J. Meehan, N. Lounis, Jong B. de, L. Rigouts y K. Andries. "Unexpected high prevalence of resistance-associated Rv0678 variants in MDR-TB patients without documented prior use of clofazimine or bedaquiline". 2016. http://hdl.handle.net/10454/17329.
Texto completoObjectives: Resistance-associated variants (RAVs) in Rv0678, a regulator of the MmpS5-MmpL5 efflux pump, have been shown to lead to increased MICs of bedaquiline (2- to 8- fold) and clofazimine (2- to 4-fold). The prevalence of these Rv0678 RAVs in clinical isolates and their impact on treatment outcomes are important factors to take into account in bedaquiline treatment guidelines. Methods: Baseline isolates from two bedaquiline MDR-TB clinical trials were sequenced for Rv0678 RAVs and corresponding bedaquiline MICs were determined on 7H11 agar. Rv0678 RAVs were also investigated in non-MDRTB sequences of a population-based cohort. Results: Rv0678 RAVs were identified in 23/347 (6.3%) of MDR-TB baseline isolates. Surprisingly, bedaquiline MICs for these isolates were high (>0.24 mg/L, n¼8), normal (0.03 0.24 mg/L, n¼11) or low(<0.03 mg/L, n¼4). A variant at position 11 in the intergenic region mmpS5–Rv0678 was identified in 39 isolates (11.3%) and appeared to increase the susceptibility to bedaquiline. In non-MDR-TB isolates, the frequency of Rv0678 RAVs was lower (6/ 852 or 0.7%). Competition experiments suggested that rifampicin was not the drug selecting for Rv0678 RAVs. Conclusions: RAVs in Rv0678 occur more frequently in MDR-TB patients than previously anticipated, are not associated with prior use of bedaquiline or clofazimine, and in the majority of cases do not lead to bedaquiline MICs above the provisional breakpoint (0.24mg/L). Their origin remains unknown. Given the variety of RAVs in Rv0678 and their variable effects on the MIC, only phenotypic drug-susceptibility methods can currently be used to assess bedaquiline susceptibility.
This work was supported by Janssen Pharmaceutica. N. C. was supported by a Baekeland PhD scholarship from the Flemish Institute for Scientific Technology (IWT 130308, Belgium). C. J. M., L. R. and B. d. J. were supported by a European Research Council Starting Grant INTERRUPTB (311725).
Maity, Koustav. "Structure Analysis Of FabI And FabZ Enzymes Of The Fatty Acid Biosynthesis Pathway Of Plasmodium Falciparum". Thesis, 2010. https://etd.iisc.ac.in/handle/2005/2221.
Texto completoMaity, Koustav. "Structure Analysis Of FabI And FabZ Enzymes Of The Fatty Acid Biosynthesis Pathway Of Plasmodium Falciparum". Thesis, 2010. http://hdl.handle.net/2005/2221.
Texto completoLibros sobre el tema "Rv0158"
Kjv. Vest-Pocket New Testaments With Psalms and Proverbs: KJV Burgundy Imitation Leather/Style Rv054. National Publishing Company, 1997.
Buscar texto completo